Nurse Practitioner, Family · Stanford, KY
NPI
1346727112
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
100 Jay St
Stanford, KY, 40484
Phone (859) 583-7870
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$14K
164 prescriptions
Company payments, 2025
$585
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jesslyn B Kelsey prescribed most often to Medicare patients was Metronidazole, with 26 prescriptions and refills. In total Jesslyn B Kelsey wrote 164 Medicare prescriptions that cost $14K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metronidazole Generic | 26 | 26 | Under 11 | $955 |
| Fluconazole Generic | 17 | 17 | 14 | $79.62 |
| Minivelle Estradiol | 13 | 13 | Under 11 | $3,047 |
| Triamcinolone Acetonide Generic | 12 | 12 | Under 11 | $120 |
Brand drugs: 27 claims; generic drugs: 137 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jesslyn B Kelsey $585 ($585 in general payments such as food, travel and fees) from 11 companies. The largest payer was Lilly USA, LLC with $142.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 11 | $142 |
| Biogen, Inc. BIIB | 6 | $122 |
| Abbvie Inc. ABBV | 4 | $64.89 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $53.9 |
| Verona Pharma, Inc. VRNA | 2 | $49.03 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $44.86 |
| Astellas Pharma US Inc 4503.T | 2 | $33.64 |
| Axsome Therapeutics, Inc. AXSM | 2 | $30.31 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $15.9 |
| Exact Sciences Corporation EXAS | 1 | $14.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.